Home
Daewon Pharmaceutical

Daewon Pharmaceutical Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domaindaewonpharm.com

Year Founded1958

Employees501 - 1000

Annual Revenue$200M - $500M

Daewon Pharmaceutical

Daewon Pharmaceutical (including company regionals)

daewonpharm.com

See more website traffic and engagement information

Daewon Pharmaceutical Revenue up to November 2025 is 200M - 500M

revenue generated by Daewon Pharmaceutical top domains

Daewon Pharmaceutical top domains revenue over 3 years

Revenue for Daewon Pharmaceutical top domains

daewonpharm.com200M - 500M

See more with Sales Intelligence

Total visits to Daewon Pharmaceutical's top domains

Understand Daewon Pharmaceutical market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

daewonpharm.com120.4K

See more with Sales Intelligence

Avg. visit duration in Daewon Pharmaceutical's top domains

Analyze Daewon Pharmaceutical engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

daewonpharm.com00:19:22

See more with Sales Intelligence

Avg. pageviews on Daewon Pharmaceutical's top domains

See how Daewon Pharmaceutical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

daewonpharm.com11.67

See more with Sales Intelligence

Daewon Pharmaceutical top competitors by domain

Top similar sites in November 2025, ranked by their affinity

dapharm.comCompany NameDong-A PharmaceuticalEmployees1001 - 5000HQKorea, Republic of, SeoulAnnual revenue--Total visits47.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Daewon Pharmaceutical

These are the website technologies, by industry, used by Daewon Pharmaceutical top domains

Advertising (2)

DoubleClick

Conversion & Analytics (2)

Google Analytics

Email Services (2)

G Suite

Social (2)

Instagram

More Technologies

5

See all

News & Signals from Daewon Pharmaceutical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDaewonpharm launches Pelubi-S.Seoul, South Korea - DaeWon Pharmaceutical has announced the launch of Pelubi-S, an enhanced version of its popular analgesic, Pelubi.

NewsDaewonpharm is developing Novo Nordisk's Wegoby injection.Daewon and Raphas have been researching to develop Novo Nordisk's Wegoby (semaglutide) injection into a microneedle patch.